Correspondence 0001104659-24-122562 from MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: Nov. 25, 2024 · CIK: 0001680048 · Accession: 0001104659-24-122562
AI Filing Summary & Sentiment
File numbers found in text: 333-283420
Show Raw Text
CORRESP
1
filename1.htm
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
VIA EDGAR
November 25, 2024
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re:
Mustang Bio, Inc.
Registration Statement on Form S-3 (Reg. No. 333-283420)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Mustang Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange
Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form
S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:01 p.m. Eastern
time, on November 27, 2024, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or Alexander Yarbrough,
both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Hamilton Sanders LLP, to orally modify or withdraw
this request for acceleration.
Once the Registration Statement
has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Yarbrough at (704) 998-4077.
Thank you for your assistance
in this matter.
Very truly yours,
Mustang Bio, Inc.
/s/ Manuel Litchman
Name:
Manuel Litchman, M.D.
Title:
President, Chief Executive Officer and Director
cc (via email):
Rakesh Gopalan and Alexander Yarbrough, Troutman Pepper Hamilton Sanders LLP